backtop


Print 6 comment(s) - last by Ammohunt.. on Jan 21 at 2:38 PM


Presenilin normally plays a role in Alzheimer's disease  (Source: employees.csbsju.edu)
The protein presenilin helps navigate embryonic motor neurons within a network of chemical cues in order to make necessary connections to wire the nervous system

Salk Institute researchers have found that the protein presenilin, which is normally associated with Alzheimer's disease, has some good qualities to it after all. 

Samuel Pfaff, Ph.D., study leader and a professor in the Gene Expression Laboratory at the Salk Institute, along with Ge Bai, a postdoctoral researcher, and a team of scientists, have discovered that presenilin not only plays a role in Alzheimer's disease, but also has a good role in helping motor neurons navigate chemical cues when locating their appropriate targets. 

Presenilin is a protein that operates as part of the gamma-secretase complex, which severs the amyloid precursor protein. This leads to a build-up of beta amyloid fragments, and in Alzheimer's disease, these fragments develop insoluble, hard plaques. 

But presenilin is not always the villain within our bodily functions, as Pfaff and his team discovered. While searching for genes involved in the nervous system during fetal development, the researchers found that presenilin acts as an usher in guiding motor neurons to their proper destination during the embryonic stage. 

Normal development consists of trillions of neurons "reaching" for others with their long extensions, called axons, in an attempt to make a connection and wire the nervous system. Motor neurons have to travel a long distance to find their targets, and at many intersections along the way, chemical cues attract or repel the neurons in an attempt to guide them. While studying this process, Pfaff and his team found that axons "switch allegiances when they reach a critical junction," which allows a small number of genes to control axonal growth by regulating the cues' effects in spacial and temporal ways. The Salk Institute team discovered that presenilin plays the part in controlling axon guidance signals.

"Because of the vast number of neurons in the nervous system, ensuring that every single cell is on target creates more biological complexity than we can account for with the genetic information encoded in our genome," said Pfaff. "There are an estimated 100 trillion connections in our brain and only about 20,000 genes."

Pfaff proposed that abnormal presenilin might be a part of the cause of Alzheimer's disease in humans because this would cause a "deregulation" of guidance on the presenilin's part. 

To see if this was the case, the team used mouse models that were engineered to have their neurons glow green. The team was able to see which mutant mice had poorly developed motor neuron function. 

Pfaff engineered one mouse with a defect from the gene coding for presenilin, and found that motor neurons were unable to exit through the spine. Instead, they would get stuck at the midline, which is a row of cells in the middle of the embryo. Netrin, which is expressed by the midline, attracts neurons in presenilin mutant mice while the motor neurons in normal mice are able to ignore the Netrin's tempting calls because of a Slit/Robo tag team. This allows them to travel to the periphery. 

But without normal presenilin, Netrin receptor fragments that are not affected by the Slit/Robo tag team can build up within the cell and make motor neurons attracted to Netrin.

"The most satisfying thing we have learned about presenilin is that this is a component that is not directly involved in the detection of signals either as a ligand or a receptor, but functions as a very important regulator of their spatiotemporal activity," said Bai. 

This study was published in Cell.



Comments     Threshold


This article is over a month old, voting and posting comments is disabled

Yawn
By Ammohunt on 1/19/2011 1:47:01 PM , Rating: -1
Hard to gauge the significance of this since I( like many other I am sure) don’t read scientific journals on a daily basis or run in circles that do. Seems like this is a “look at how smart and cool I am that I read this stuff” article




RE: Yawn
By DFranch on 1/19/2011 2:25:40 PM , Rating: 2
I won't pretend that it was an easy read, but please don't pretend to speak for all readers on the of DailyTech. My wife's family has a history of Alzheimer's I like to read about new discoveries which can lead to a cure.


RE: Yawn
By Ammohunt on 1/21/2011 2:38:16 PM , Rating: 2
You have missed the point entirely the article says nothing in regards to how this advances toward a cure for Alzheimers so they know more about a particluar enzyme they thought was bad previously. so what.


RE: Yawn
By morphologia on 1/19/2011 2:42:30 PM , Rating: 2
If this is a “look at how smart and cool I am that I read this stuff” article, then I guess your comment is a "look how cool I am that I make snarky comments about things I don't understand." Seriously...why bother posting if you have nothing useful to say?

I know several people who find this interesting; granted, most of them are studying neurodegenerative processes and corresponding treatments, but the point is...they read DailyTech.


RE: Yawn
By HeavyB on 1/19/2011 2:54:34 PM , Rating: 2
Quite a few of the scientific breakthroughs that are highlighted at Dailytech are published in journals that are not top rate, which is a good indication of their scientific impact (although not 100% correlative). This work was published in Cell , the top rated journal for full length manuscripts covering the topic of cell biology. That's a pretty good barometer of its significance.


"The whole principle [of censorship] is wrong. It's like demanding that grown men live on skim milk because the baby can't have steak." -- Robert Heinlein














botimage
Copyright 2014 DailyTech LLC. - RSS Feed | Advertise | About Us | Ethics | FAQ | Terms, Conditions & Privacy Information | Kristopher Kubicki